Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.

导出 LinkOut

翻译打印收藏纠错

第一作者： J,Ronald

第一单位： Division of Vascular & Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, 27710 Durham, NC, USA. Electronic address: james.ronald@duke.edu.

作者： J,Ronald ^[1] ; Q,Wang ^[2] ; S S,Choi ^[3] ; P V,Suhocki ^[4] ; M D,Hall ^[4] ; T P,Smith ^[4] ; C Y,Kim ^[4]

作者单位： Division of Vascular & Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, 27710 Durham, NC, USA. Electronic address: james.ronald@duke.edu. ^[1] Division of Vascular & Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, 27710 Durham, NC, USA; Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan, China. ^[2] Division of Gastroenterology, Department of Medicine, Duke University Medical Center, 2301 Erwin Road, 27710 Durham, NC, USA. ^[3] Division of Vascular & Interventional Radiology, Department of Radiology, Duke University Medical Center, 2301 Erwin Road, 27710 Durham, NC, USA. ^[4]

关键词 Albumin-bilirubin (ALBI) grade Liver cirrhosis Model for end-stage liver disease (MELD) score Survival study Transjugular intrahepatic portosystemic shunt (TIPS)